UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

The Journal of clinical investigation, 2002-12, Vol.110 (11), p.1659-1666

2002

Volltextzugriff (PDF)

Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome

Kidney360, 2024-08, Vol.5 (8), p.1197-1199

2024

Volltextzugriff (PDF)

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

Clinical pharmacology in drug development, 2023-12, Vol.12 (12), p.1211-1220

2023

Volltextzugriff (PDF)

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

Nature genetics, 2006-12, Vol.38 (12), p.1397-1405

2006

Volltextzugriff (PDF)

Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential

The Journal of experimental medicine, 2003-10, Vol.198 (8), p.1201-1212

2003

Volltextzugriff (PDF)

Proteomic Analysis in Pediatric Renal Disease

Seminars in nephrology, 2007-11, Vol.27 (6), p.652-657

2007

Volltextzugriff (PDF)

How Often Do Safety Signals Occur by Chance in First‐in‐Human Trials?

Clinical and translational science, 2018-09, Vol.11 (5), p.471-476

2018

Volltextzugriff (PDF)

Economic Evaluation of a Bayesian Model to Predict Late-Phase Success of New Chemical Entities

Value in health, 2007-09, Vol.10 (5), p.377-385

2007

Volltextzugriff (PDF)

Urinary Proteome Profiling to Search for Biomarkers in Steroid-Resistant Nephrotic Syndrome

Contributions to nephrology, 2008-01, Vol.160, p.29-36

2008

Volltextzugriff (PDF)

Clinical forecasting in drug development

Nature reviews. Drug discovery, 2007-02, Vol.6 (2), p.107-108

2007

Volltextzugriff (PDF)

Drug target-gene signatures that predict teratogenicity are enriched for developmentally related genes

Reproductive toxicology (Elmsford, N.Y.), 2011-05, Vol.31 (4), p.562-569

2011

Volltextzugriff (PDF)

Computational simulation of renal biopsy accuracy in focal segmental glomerulosclerosis

Pediatric nephrology (Berlin, West), 2006-07, Vol.21 (7), p.953-957

Schachter, Asher D

2006

Volltextzugriff (PDF)

Paediatric drug development

Nature reviews. Drug discovery, 2007-06, Vol.6 (6), p.429-430

2007

Volltextzugriff (PDF)

Urine proteomic profiling of pediatric nephrotic syndrome

Pediatric nephrology (Berlin, West), 2006-09, Vol.21 (9), p.1257-1265

2006

Volltextzugriff (PDF)

On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes

Journal of the American Society of Nephrology, 2005-06, Vol.16 (6), p.1542-1548

2005

Volltextzugriff (PDF)

The pediatric nephrotic syndrome spectrum: Clinical homogeneity and molecular heterogeneity

Pediatric transplantation, 2004-08, Vol.8 (4), p.344-348

Schachter, Asher D.

2004

Volltextzugriff (PDF)

SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions

Proteomics (Weinheim), 2006-03, Vol.6 (5), p.1676-1680

2006

Volltextzugriff (PDF)

Limited sampling strategies for sirolimus after pediatric renal transplantation

Pediatric transplantation, 2009-12, Vol.13 (8), p.1020-1026

2009

Volltextzugriff (PDF)

Subcutaneous VIS649, an APRIL-Neutralizing Antibody: Preliminary Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of VIS649-102, a Phase 1, Single Ascending Dose Study in Healthy Volunteers: PO2024

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.621-622

2021

Volltextzugriff (PDF)

Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol

Pediatric transplantation, 2004-04, Vol.8 (2), p.171-177

2004

Volltextzugriff (PDF)

Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) are a Spectrum of a Single Disease Within Immune-Mediated Nephrotic Syndrome

Kidney360, 2024-07

2024

Volltextzugriff (PDF)

Incidence Rates of Primary Focal Segmental Glomerulosclerosis (FSGS) Within a Diverse Adult Southern California Population, 2010-2021: TH-PO640

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.270-270

2023

Volltextzugriff (PDF)

Incidence of Primary Immunoglobulin A Nephropathy (IgAN) Among a Diverse Population in the United States: TH-PO690

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.283-283

2023

Volltextzugriff (PDF)

ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population: TH-PO615

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.263-263

2023

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(27)
Biological And Medical Sciences
(14)
Child
(13)
Medical Sciences
(13)
Pediatrics
(12)
Urology & Nephrology
(10)
Transplantation
(9)
Female
(8)
Nephrotic Syndrome
(7)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(7)
Animals
(6)
Kidney Transplantation
(6)
Male
(6)
Surgery Of The Urinary System
(6)
Adult
(5)
Child, Preschool
(5)
Children
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential

Proteomic Analysis in Pediatric Renal Disease

How Often Do Safety Signals Occur by Chance in First‐in‐Human Trials?

Economic Evaluation of a Bayesian Model to Predict Late-Phase Success of New Chemical Entities

Urinary Proteome Profiling to Search for Biomarkers in Steroid-Resistant Nephrotic Syndrome

Clinical forecasting in drug development

Drug target-gene signatures that predict teratogenicity are enriched for developmentally related genes

Computational simulation of renal biopsy accuracy in focal segmental glomerulosclerosis

Paediatric drug development

Urine proteomic profiling of pediatric nephrotic syndrome

On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes

The pediatric nephrotic syndrome spectrum: Clinical homogeneity and molecular heterogeneity

SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions

Limited sampling strategies for sirolimus after pediatric renal transplantation

Subcutaneous VIS649, an APRIL-Neutralizing Antibody: Preliminary Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of VIS649-102, a Phase 1, Single Ascending Dose Study in Healthy Volunteers: PO2024

Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol

Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) are a Spectrum of a Single Disease Within Immune-Mediated Nephrotic Syndrome

Incidence Rates of Primary Focal Segmental Glomerulosclerosis (FSGS) Within a Diverse Adult Southern California Population, 2010-2021: TH-PO640

Incidence of Primary Immunoglobulin A Nephropathy (IgAN) Among a Diverse Population in the United States: TH-PO690

ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population: TH-PO615

Suchergebnisse filtern